Original Research
Published on 26 Aug 2020
miR-452 Reverses Abnormal Glycosylation Modification of ERα and Estrogen Resistance in TNBC (Triple-Negative Breast Cancer) Through Targeting UGT1A1
in Cancer Metabolism
Frontiers in Oncology
doi 10.3389/fonc.2020.01509
- 5,455 views
- 14 citations
